0001144204-19-037694.txt : 20190905 0001144204-19-037694.hdr.sgml : 20190905 20190805171740 ACCESSION NUMBER: 0001144204-19-037694 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InMode Ltd. CENTRAL INDEX KEY: 0001742692 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: TAVOR BUILDING, SHA?AR YOKNEAM STREET 2: POB 533 CITY: YOKNEAM STATE: L3 ZIP: 2069200 BUSINESS PHONE: 972-4-9097470 MAIL ADDRESS: STREET 1: TAVOR BUILDING, SHA?AR YOKNEAM STREET 2: POB 533 CITY: YOKNEAM STATE: L3 ZIP: 2069200 CORRESP 1 filename1.htm

  

August 5, 2019

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attn: Ms. Heather Percival

Mr. Russell Mancuso

 

Re: InMode Ltd. (the “Company”)

Registration Statement on Form F-1 (File No. 333-232615)

 

Acceleration Request

  Requested Date:    Wednesday, August 7, 2019

  Requested Time:    4:00 p.m. Eastern Daylight Time

 

Ladies and Gentlemen:

 

As representatives of the several underwriters of the Company’s proposed public offering, we hereby join the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will be declared effective at 4:00 p.m., Eastern Daylight Time, on August 7, 2019, or as soon thereafter as is practicable, or at such later time as the Company may orally request.

 

Pursuant to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus, dated July 29, 2019, through the date hereof:

 

Preliminary Prospectus dated July 29, 2019:

 

715 copies to prospective underwriters, institutional investors, dealers and others

 

The undersigned advises that it has complied and will continue to comply, and that it has been informed by the participating underwriters and dealers that they have complied, and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

 

[Remainder of Page Intentionally Left Blank]

 

 

 

 

 

 

 

 

 

 

 

 

Very truly yours,

 

As Representatives of the several underwriters

 

  

BARCLAYS CAPITAL INC.  
     
By: /s/ Victoria Hale  
  Name: Victoria Hale  
  Title: Vice President  

 

 

UBS SECURITIES LLC  
     
By: /s/ M. Robert DiGia  
  Name: M. Robert DiGia  
  Title: Global Head of Healthcare, Managing Director  

 

 

UBS SECURITIES LLC  
     
By: /s/ Jonathan Waksman  
  Name: Jonathan Waksman  
  Title: Associate Director  

 

 

 

 

[Signature Page to Underwriter Acceleration Request]